KCPG
EW icon

Kavar Capital Partners Group’s Edwards Lifesciences EW Stock Holding History

Kavar Capital Partners Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,497
Closed -$703K – 184
2024
Q4 		$703K Sell
9,497
-1,380
-13% -$96.6K 0.12% 105
2024
Q3 		$718K Sell
10,877
-1,417
-12% -$103K 0.11% 108
2024
Q2 		$1.14M Sell
12,294
-1,090
-8% -$96.5K 0.2% 88
2024
Q1 		$1.28M Sell
13,384
-14,764
-52% -$1.24M 0.24% 82
2023
Q4 		$2.15M Buy
28,148
+7,309
+35% +$509K 0.24% 81
2023
Q3 		$1.44M Sell
20,839
-1,245
-6% -$100K 0.31% 75
2023
Q2 		$2.08M Sell
22,084
-527
-2% -$45.8K 0.44% 64
2023
Q1 		$1.87M Sell
22,611
-470
-2% -$36.9K 0.4% 66
2022
Q4 		$1.72M Sell
23,081
-4,270
-16% -$329K 0.4% 67
2022
Q3 		$2.26M Buy
27,351
+209
+0.8% +$20.1K 0.58% 52
2022
Q2 		$2.58M Buy
27,142
+1,163
+4% +$120K 0.6% 50
2022
Q1 		$3.06M Buy
25,979
+143
+0.6% +$16K 0.66% 44
2021
Q4 		$3.35M Buy
25,836
+481
+2% +$56.1K 0.7% 44
2021
Q3 		$2.87M Buy
25,355
+235
+0.9% +$26.8K 0.65% 46
2021
Q2 		$2.6M Buy
25,120
+715
+3% +$67.4K 0.63% 48
2021
Q1 		$2.04M Buy
24,405
+145
+0.6% +$12.3K 0.55% 60
2020
Q4 		$2.21M Buy
24,260
+15,870
+189% +$1.32M 0.64% 49
2020
Q3 		$670K Buy
8,390
+705
+9% +$55K 0.23% 84
2020
Q2 		$531K Buy
+7,685
New +$546K 0.2% 85

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Kavar Capital Partners Group's EW Position: Q1 2025 in Review

Kavar Capital Partners Group sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 9,497 shares — an estimated $703K sold.

Kavar Capital Partners Group first reported a position in EW in Q2 2020 and held it in 19 quarters. The position peaked at $3.35M in Q4 2021. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Kavar Capital Partners Group reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Kavar Capital Partners Group sold 9,497 Edwards Lifesciences shares in Q1 2025, an estimated $703K.
  • Kavar Capital Partners Group first reported a position in Edwards Lifesciences in Q2 2020 and held it in 19 quarters.
  • Kavar Capital Partners Group's Edwards Lifesciences position peaked at $3.35M in Q4 2021.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Kavar Capital Partners Group's 13F filing for Q1 2025, filed 23 Apr 2025.